text-only page produced automatically by LIFT Text Transcoder Skip all navigation and go to page contentSkip top navigation and go to directorate navigationSkip top navigation and go to page navigation
National Science Foundation
 
News
design element
News
News From the Field
For the News Media
Special Reports
Research Overviews
NSF-Wide Investments
Speeches & Lectures
NSF Current Newsletter
Multimedia Gallery
News Archive
News by Research Area
Arctic & Antarctic
Astronomy & Space
Biology
Chemistry & Materials
Computing
Earth & Environment
Education
Engineering
Mathematics
Nanoscience
People & Society
Physics
 


Press Release 07-048
Alzheimer's, Parkinson's, Type 2 Diabetes Similar at Molecular Level

Protein analysis may offer new therapeutic route

Micro-crystals help find tiny structures in Alzheimer's, other diseases, shown against a U.S. dime.

Micro-crystals help find tiny structures in Alzheimer's, other diseases, shown against a U.S. dime.
Credit and Larger Version

April 30, 2007

Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease, and other degenerative diseases are more closely related at the molecular level than scientists realized, a team reports this week in an advanced online publication of the journal Nature.

While still preliminary, the research, could help scientists develop tools for diagnosing such diseases, and potentially for treating them through "structure-based drug design," said David Eisenberg, a UCLA chemist and molecular biologist who is part of the research team.

The researchers studied the harmful rope-like structures known as amyloid fibrils--linked protein molecules that form in the brain. The fibrils contain a stack of water-tight "molecular zippers."

"With each disease, a different protein transforms into amyloid fibrils, but all of these diseases are similar at the molecular level," Eisenberg said.

If the molecular zipper is universal in amyloid fibrils, as Eisenberg believes, is it possible to pry open the zipper or prevent its formation?

Eisenberg's research team used X-ray analysis and a sophisticated computer algorithm to study proteins known to be associated with human diseases. When the computer said a protein will form an amyloid fibril, it almost always did. And one team member is experimenting with various compounds to break up the fibrils.

"Structural analysis of micro-crystals of proteins is an example of how basic research can have a profound impact on our understanding of health, biotechnology and other practical issues," said Parag Chitnis, program director in National Science Foundation's (NSF) Division of Molecular and Cellular Biosciences.

NSF, the Howard Hughes Medical Institute and the National Institutes of Health supported the research.

See the UCLA news release at http://www.newsroom.ucla.edu/page.asp?RelNum=7899&menu=fullsearchresults.

-NSF-

Media Contacts
Cheryl Dybas, NSF (703) 292-7734 cdybas@nsf.gov
Stuart Wolpert, UCLA (310) 206-0511 swolpert@support.ucla.edu

The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering, with an annual budget of $6.06 billion. NSF funds reach all 50 states through grants to over 1,900 universities and institutions. Each year, NSF receives about 45,000 competitive requests for funding, and makes over 11,500 new funding awards. NSF also awards over $400 million in professional and service contracts yearly.

 Get News Updates by Email 

Useful NSF Web Sites:
NSF Home Page: http://www.nsf.gov
NSF News: http://www.nsf.gov/news/
For the News Media: http://www.nsf.gov/news/newsroom.jsp
Science and Engineering Statistics: http://www.nsf.gov/statistics/
Awards Searches: http://www.nsf.gov/awardsearch/

 

border=0/


Print this page
Back to Top of page
  Web Policies and Important Links | Privacy | FOIA | Help | Contact NSF | Contact Webmaster | SiteMap  
National Science Foundation
The National Science Foundation, 4201 Wilson Boulevard, Arlington, Virginia 22230, USA
Tel:  (703) 292-5111, FIRS: (800) 877-8339 | TDD: (800) 281-8749
Last Updated:
May 18, 2007
Text Only


Last Updated: May 18, 2007